Integra LifeSciences (NASDAQ: IART) — Company Overview, News & Financial Data
Integra LifeSciences develops medical technology solutions focused on neurosurgery and regenerative medicine to improve patient care.
Integra LifeSciences
Integra LifeSciences (NASDAQ:IART) specializes in developing, manufacturing, and marketing innovative solutions in the medical technology sector. Focused primarily on neurosurgery, regenerative medicine, and extremity orthopedics, Integra works towards improving patients' lives through extensive research and cutting-edge technology. Their operations span the production of surgical instruments, implants, and tissue-based products designed to facilitate healing in complex surgical procedures. With a global footprint, Integra's projects aim at addressing some of the most challenging medical issues today, striving to provide reliable solutions for surgeons and offering better outcomes for patients worldwide. The company's objectives center around continuous innovation, expanding their product portfolio, and maintaining a strong ethical stance in all their endeavors, aligning with their commitment to health and safety.
Snapshot
Operations
Products and/or services of Integra LifeSciences
- Advanced wound care products, focusing on therapies for wound healing and skin regenerations.
- DuraGen Dural Graft Matrix, designed for dural closure in neurosurgery to prevent cerebrospinal fluid leakage.
- Orthopedics solutions, including hardware and regenerative technology for extremity surgery.
- Tissue technologies, offering regenerative products for soft tissue repair and reconstruction.
- Surgical instruments, comprised of specialty surgical tools and instruments for neurosurgery, spine, and ENT procedures.
- Codman Specialty Surgical products, providing precision instruments and devices for neurosurgery and critical care.
Integra LifeSciences executive team
- Stuart M. EssigCEO, President & Chairman
- Lea Daniels KnightExecutive VP & CFO
- Robert T. Davis Jr.Executive Vice President of Tissue Reconstruction and Distributed Technologies
- Michael J. McBreenExecutive VP & Chief Commercial Officer
- Harvinder Pal SinghExecutive VP & President of International Business
- Jeffrey A. MosebrookSenior VP of Finance & Principal Accounting Officer
- Teshtar ElaviaCorporate VP & Chief Technology Officer
- Christopher WardSenior Director of Investor Relations
- Michael D. HutchinsonExecutive VP, Chief Legal Officer & Secretary
- Laurene IsipVice President of Global Corporate Communications & Public Relations